SCHEMBL2494639

SCHEMBL2494639

CS(=O)(=O)N(c1ccc(-c2nc(C(=O)c3ccc(F)cc3)cn2S(=O)(=O)c2ccccc2)cc1)S(C)(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.39
HTR6 P50406 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA9 Q16790 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HTR2A P28223 1/20 0.35
HTR7 P34969 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGA2 P17301 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL725514 0.90 CNR2 (0.41) PTGS2HTR6SMN1; SMN2HSD17B10CA1
SCHEMBL723249 0.88 NR1H2 (0.41) PTGS2SMN1; SMN2HSD17B10CA1CA2
SCHEMBL723239 0.88 SMN1; SMN2 (0.42) PTGS2SMN1; SMN2HSD17B10CA1CA2
SCHEMBL724744 0.86 GABRA2 (0.44) HTR6SMN1; SMN2HSD17B10CA1CA2
SCHEMBL724319 0.85 MAPT (0.45) PTGS2SMN1; SMN2CA1CA2CA4
SCHEMBL786748 0.82 NR1H2 (0.45) HTR6SMN1; SMN2CA1CA2CA4
SCHEMBL724671 0.81 MCL1 (0.47) LMNAKMT2AMEN1
SCHEMBL724176 0.81 CA1 (0.41) PTGS2HSD17B10CA1CA2CA4
SCHEMBL724831 0.80 NR1H2 (0.48) SMN1; SMN2CA1CA2CA4CA9
SCHEMBL770420 0.80 SMN1; SMN2 (0.48) PTGS2SMN1; SMN2HSD17B10ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542081-A1 COMPOUNDS FOR TREATMENT OF CANCER Gtx, Inc. (US) 2013-01-09 EP disclosed
WO-2011109059-A1 COMPOUNDS FOR TREATMENT OF CANCER GTX, INC. (US) 2011-09-09 WO disclosed